Join our mission

Join our team of industry leaders, scientists and clinicians in Boston, MA and Cambridge, UK as we unlock the transformative potential of NLRP3 inhibition and drive toward the first Phase 3 trial of a brain-penetrant NLRP3 inhibitor in cardiometabolic disease. With a focused, differentiated clinical stage pipeline and clear line of sight to late-stage development, this is just the beginning of our mission to deliver targeted medicines for cardiometabolic and neuroinflammatory diseases that impact billions of people as they age.

NodThera is an equal opportunity employer. We value a diverse and inclusive work culture for all employees, regardless of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status or disability status.

Here are our currently open roles:

General Counsel

Location: Boston, MA, USA
Headshot of Alan Watt, PhD, MBA, Chief Scientific Officer of NodThera.”
Alan Watt, PhD, MBA 
Founder & Chief Scientific Officer
NodThera is in the first wave of companies to explore the clinical utility of NLRP3 inhibitors. NLRP3 is now one of the most biologically and genetically validated therapeutic targets of our time – the next frontier is employing the chemistry that will inhibit NLRP3.
Alan Watt, PhD, MBA 
Founder & Chief Scientific Officer
Valerie Reader
Vice President of Scientific Operations
NodThera’s cutting-edge, fast-paced and friendly environment makes it a very exciting place to work.
Valerie Reader
Vice President of Scientific Operations